Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Kongsberg Automotive reports Q3 2017 results

The Q3 2017 Report follows attached. ****************************************************************************************************************** Third quarter 2017 highlights include: Revenues were MEUR 240.7 in the third quarter, MEUR 22.4 (10.3%) above the third quarter last year, including negative currency translation effects of MEUR 5.2.Adjusted EBIT amounted to MEUR 7.7 in the third quarter, MEUR 7.1 above the third quarter last year.During the third quarter, KA announced the closure of the Easley facility in the United States.Annualized business wins in the

Capital Markets Day 2017

Presentation and Video WebcastPresentation for the CMD 2017 follows attached. The Video Webcast starts at 10.00 CET, Nov. 8, 2017. You can access the Video Webcast with the following link:  https://secure-web.cisco.com/1cqA3MqMb4aE2zzm96uBj8oFu0avdp7hhvSGS6sh55CPpvjj975cFXO2uYPmZLYKHto0cvtFHpUolFm12swCA6UIM3HZW1BB1FcmE_ZhNn5c8mfeU8pxSkcNC6xpgijoSElrebvBq4q1aJMiczvWBxBE9NOdzWHe53Sr5OW7yeOPxxjCOZQRVUiSn4-3SOQO1IFDCgMoEWQSo2-uGa1fVVHXakS4Za5BTHTPQo82091uPu9LnNRBYsG09Ti2hhrXi8uqqVKoo_DnGw1lDQJwwVQ/https%3A%2F%2Fpgi.webcasts.com%2Fstarthere.jsp%3Fei%3D1166288%26tp_key%3Db6ef2b00bb

Lundbeck increased operating profit (EBIT) with 126% and EPS by 182% in the first nine months of 2017

HIGHLIGHTS · Revenue reached DKK 12,842 million in the first nine months of 2017 representing an increase of 12% (13% in local currencies) compared to the same period last year · Revenue of Abilify Maintena® increased by 24% to DKK 995 million (24% in local currencies) · Revenue of Brintellix®/Trintellix® increased by 55% to DKK 1,195 million (54% in local currencies) · Revenue of Northera® increased by 54% to DKK 1,188 million (55% in local currency) · Revenue of Onfi® increased by 25% to DKK 2,215 million (25% in local currency) · Revenue of Rexulti®

Nomination committee for Volatis AB’s Annual General Meeting 2018

In accordance with the resolution by the Annual General Meeting 2017 in Volati, the Nomination Committee shall consist of at least three members, of which one shall be the Chairman of the Board. The other members are chosen by offering each of the two largest shareholders the possibility to each appoint a representative no later than six months prior to the Annual General Meeting. The sizes of the shareholders are based on Euroclear Sweden AB’s list of registered shareholders at the last banking day of September of the current year. The Chairman of the Nomination Committee shall, unless the

Interim-report January - September 2017

• Rental income amounted to MSEK 762 (666) in the quarter and MSEK 2,342 (1,958) in the period • Profit from property management totaled MSEK 515 (582) in the quarter, corresponding to SEK 3.09 per ordinary share (3.52), and to MSEK 1,661 (1,275) in the period, corresponding to SEK 10.01 per ordinary share (8.23). Profit from property management excluding share in profit from joint ventures amounted to MSEK 431 (358) in the quarter and MSEK 1,244 (951) in the period • Profit after tax amounted to MSEK 775 (1,389) in the quarter, corresponding to SEK 4.73 per ordinary share before

Insr Insurance Group third quarter 2017 results: Strong underwriting result and portfolio growth

Oslo, 8 November 2017 Insr Insurance Group ASA (OSE:INSR) announces its results for the third quarter of 2017.  A presentation of the results by the group’s senior management team will take place today at 08:00 and 09:00 CET - see details below. Premium portfolio volume returned to growth and ongoing pricing measures have increased average prices in the portfolio significantly. Insr recorded a profit for the third quarter with a strong underwriting result. The acquisition of Nemi Forsikring is a company transforming transaction, attractive both strategically and financially. The

Cherry's interim report for Q3 2017 - Focus on growth with enhanced profitability

SUMMARY THIRD QUARTER 2017• Group revenue increased by 165% year-on-year to MSEK 567 (214), with organic revenue growth amounting to 30%.• Profitability improved and EBITDA increased by 263% to MSEK 112 (31) and the EBITDA margin was 20% (14).• Profit for the period amounted to MSEK 42 (31).• Earnings per share before and after dilution* amounted to SEK 0.22 (0.27) and SEK 0.21 (0.27) respectively.• In the final acquisition analysis for ComeOn Malta Ltd, the previous revaluation of shares by MSEK 510 was adjusted, which does not affect profit for the year but does reduce goodwill

Raisio plc Interim Report 1-9/2017: Raisio’s net sales increased by almost 6% in July-September

Raisio plc        Interim Report 8 November 2017 at 8:30 a.m. Finnish time RAISIO’S NET SALES INCREASED BY ALMOST 6% IN JULY-SEPTEMBER July-September 2017 · The Group’s comparable net sales increased by 5.8%, totalling EUR 108.8 (102.8) million. · The Group’s comparable EBIT was EUR 13.0 (14.0) million, accounting for 12.0 (13.6)% of net sales. · Brands Division’s comparable EBIT totalled EUR 10.6 (11.1) million, accounting for 15.0 (16.2)% of net sales. · Raisioagro’s EBIT was EUR 3.3 (2.3) million, accounting for 7.9 (6.1)% of net sales. January-September 2017 ·

Interim Report 1 January – 30 September 2017

3 months ended 30 September 2017 · Local currency sales increased by 11% and Euro sales increased by 6% to €295.3m (€278.9m). · Number of registered actives was stable at 2.6m. · EBITDA amounted to €40.0m (€30.8m). · Operating margin was 11.0% (9.0%), negatively impacted by 160 bps from currencies, and operating profit was €32.5m (€25.2m). · Net profit was €17.4m (€12.7m) and diluted EPS €0.30 (€0.23). Following the successful refinancing of the Revolving Credit Facility during the quarter, the net profit was negatively impacted by a one-off amortisation of the replaced

Photocure ASA: Results for the third quarter of 2017

Oslo, Norway, 7 November 2017: Photocure ASA (OSE:PHO), today reported a revenue growth of 45% for the important US market in the third quarter of 2017, contributing to Hexvix/Cysview revenues of NOK 35.5 million (Q3 2016: NOK 31.6) and an EBITDA of NOK -0.2 million for the commercial franchise. Following the new Medicare reimbursement from 2018, Photocure increases the annual revenue ambition for 2020 to a range of USD 20 to 25 million. "Our third quarter report demonstrates continued significant progress in our US business. The new reimbursement of Blue Light Cystoscopy with Cysview

HKSCAN GROUP’S INTERIM REPORT 1 JANUARY–30 SEPTEMBER 2017: WEAK RESULT – EFFICIENCY IMPROVEMENT ACTIONS ON GOING

HKScan Corporation              INTERIM REPORT             8 November 2017, at 8:10 a.m. (EET) HKSCAN GROUP’S INTERIM REPORT 1 JANUARY–30 SEPTEMBER 2017:WEAK RESULT – EFFICIENCY IMPROVEMENT ACTIONS ON GOING   • Net sales for January–September were EUR 1 332.7 (1 387.7) million and in the third quarter EUR 452.4 (465.9) million. • EBIT for January–September was EUR -18.1 (5.5) million. Comparable EBIT was EUR -5.3 (7.2) million. The corresponding EBIT margin was -0.4 (0.5) per cent. • EBIT for the third quarter was EUR -0.8 (8.1) million. Comparable EBIT was EUR 2.7 (8.1)

Invitation: Presentation of Ambea’s third quarter report 2017

Hosts: Fredrik Gren, CEO, Daniel Warnholtz, CFO and Louise Tjeder, Director IR and Strategy.On November 17th at 07:00 (CET) Ambea will publish its third quarter report for 2017. In connection to the announcement, Ambea will host a telephone conference at 10:00 (CET) on Friday November 17th. The presentation will be held in English and is also available as webcast on ambea.com or direct link: https://edge.media-server.com/m6/p/qh3p7x6p Dial-in information: To ensure that you are connected to the conference call, please dial in a few minutes before the conference call to register

Multiconsult ASA – Repurchase of own shares

On 7 November 2017, Multiconsult ASA ("Multiconsult") purchased 5 523 of its own shares at an average price of NOK 86.35 per share. The shares were purchased in accordance with the Company's share repurchase programme as announced on 22 September 2017. The shares were acquired on Oslo Børs.Following this transaction Multiconsult holds 117 094 of its own shares.  For further information, please contact: Investor relations:      Mirza Koristovic, Head of Investor Relations      Phone: +47 93 87 05 25      E-mail: ir@multiconsult.no Media:      Gaute Christensen, VP

Changes in HKScan’s Group Leadership Team

HKScan Corporation                                   Stock Exchange Release 8 Nov 2017, at 8:00 EET   Changes in HKScan’s Group Leadership Team    Sami Sivuranta, MSc (Tech), has been appointed as HKScan’s new EVP Operations and member of the Group Leadership Team. He will join HKScan no later than the beginning of January 2018. Sivuranta will report to President and CEO Jari Latvanen. Sivuranta has extensive experience of production management and business development in challenging executive roles at numerous multinational corporations, most recently as Director of Business

UPM and the Government of Uruguay sign an investment agreement to establish a competitive operating platform for a possible new pulp mill in Uruguay

(UPM, Helsinki/Montevideo 8 November 2017 at 00:15 EET) - UPM and the Government of Uruguay have signed an investment agreement, which outlines the local prerequisites for a potential pulp mill investment. The agreement details the roles, commitments and time-line for both parties as well as the relevant items to be agreed prior to the final investment decision. The agreement defines the requirements for the operating environment of a world-class pulp mill project. The site of the mill would be close to the city of Paso de los Toros, in the department of Durazno in central Uruguay. A

UTA chemist Kevin Schug wins ACS J. Calvin Giddings Award

A chemist at The University of Texas at Arlington is the recipient of a prestigious award from the American Chemical Society for his efforts to improve the educational experience of students in the field of analytical chemistry. The ACS Division of Analytical Chemistry presented Kevin Schug, Shimadzu Distinguished Professor of Analytical Chemistry, with the 2017 J. Calvin Giddings Award for Excellence in Education. “The award recognizes scientists who have enhanced the personal and professional development of students in analytical chemistry. “Given the past recipients of this award,

Hemfosa Fastigheter evaluates the conditions for splitting the Group into two listed companies

The Board of Directors of Hemfosa Fastigheter has today decided to evaluate the conditions for splitting the Group into two listed companies. One company that will focus on community service properties and one transaction-based, opportunistic company. The purpose is to create higher shareholder value by further streamlining the operations.Since it was founded in 2009, Hemfosa has generated a significant property portfolio with a growing share of community service properties with stable long-term cash flows. Growth opportunities in the community service property sector are deemed to remain

Stora Enso introduces change in operational EBITDA definition, higher strategic target for Wood Products division and CAPEX for 2018

STORA ENSO OYJ STOCK EXCHANGE RELEASE 7 November 2017 at 18.30 EETChange in operational EBITDA definition (non-IFRS measure)Starting from the fourth quarter of 2017, Stora Enso will include the operational EBITDA of its equity accounted investments (EAI) in the group’s operational EBITDA. Previously Stora Enso has included the operational EBIT of EAIs in the group’s operational EBIT only. This change will affect the following key figures: · operational EBITDA · operational EBITDA margin · net debt to last 12 months’ operational EBITDA ratio There will be no impact on

Mandatory notification of subscription rights grant

Reference is made to the stock exchange announcement by Cxense ASA (the “Company”) earlier today, regarding issuance of subscriptions rights (“SRs”) to employees in the Company under the Company’s 2017 incentive subscription rights plan, as adopted by the Company’s annual general meeting on 10 May 2017. The strike price for the issued SRs is NOK 39.23The following primary insiders were granted SRs under the Company’s 2017 incentive subscription rights plan: Jørgen Loeng, CFO, was granted 35,000 SRs. Following the grant, Mr. Loeng holds 35,000 SRs and 44,350 shares (shares held through

Subscription Rights Grant

On 7 November 2016, the Board of Directors of Cxense ASA (the “Company”) resolved to issue 272,500 subscription rights ("SRs") to employees in the Company. The grant is subject to the employees accepting that share options and SRs issued prior to this issue are deleted, in total 113,325 SRs and 9,200 share options. The grant was made under the Company's 2017 incentive subscription rights plan, as adopted by the Company’s annual general meeting on 10 May 2017. The exercise price of the SRs is NOK 39.23 per share. The issued SRs vest over 4 years by 25 % on each anniversary from the date

#17-1049 Delisting of instrument issued by Commerzbank AG

After the end of today’s trading, 1 instrument issued by Commerzbank AG will be delisted from NDX Sweden.For more details see attached files. For further information concerning this NDX notice please contact: NDX Listing on +46 8 566 390 10 or at ndxlist@ngm.se Nordic Growth Market NGM AB About NDX Nordic derivatives Exchange (NDX) is a market for listing and trading of derivatives and other structured products. The market is operated by Nordic Growth Market (www.ngm.se), a regulated exchange under the supervision of the Swedish Financial Supervisory Authority. NDX offers

A waiver on bank loans was received on expected breaches of loan covenants as of 31 December 2017

The lender has approved a waiver request from Endomines relating to expected breach on loan covenants as of 31 December 2017. The guarantor, Finnvera, has given its consent to this waiver. Terms and conditions in the loan agreement remain thereby unchanged. In the waiver received today the bank and the guarantor have temporarily waived the Company´s testing obligation in respect of Minimum Equity Ratio, Minimum EBITDA and Minimum level of Cash and Cash Equivalents regarding the Accounting Date of 31 December 2017. Total bank loans subject to the waiver amount to 74.1 MSEK (EURSEK at 9.

Oncopeptides to attend the Jefferies Healthcare Conference in London on November 16th

Stockholm – November 7, 2017 - Oncopeptides AB (Nasdaq Stockholm: ONCO) announced today that they will attend Jefferies annual Healthcare Conference in London on November 16th.Oncopeptides is a research and development stage pharmaceutical company developing drugs for the treatment of cancer. Since the founding of the company, the focus has primarily been on the development of the lead product candidate Ygalo®, an innovative, peptidase-potentiated alkylator intended for effective and focused treatment of hematological cancers, and in particular multiple myeloma. Ygalo® has been used to

Nexam Chemical receives the first commercial order from Diab for NEXAMITE®-masterbatch

Diab, a global leader within core materials for various types of demanding composite constructions has placed its first major order of NEXAMITE®-based masterbatch. The order value amounts to approximately SEK 600 thousand and delivery will take place during the fourth quarter.The launch of high performance PET-foam has started, with NEXAMITE®-technology forming an essential part. The PET-foam contains Nexam Chemical’s property enhancing additive NEXAMITE®, delivered in masterbatch formulation. Using NEXAMITE® in masterbatch formulation simplifies customers production process and secures a

There are no items matching the current filter
There are no more items matching the current filter
Back to top